Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3333542 | Seminars in Hematology | 2014 | 16 Pages |
Abstract
Advancements in sequencing techniques have led to the discovery of numerous genes not previously implicated in acute myeloid leukemia (AML) biology. Further in vivo studies are necessary to discern the biological impact of these mutations. Murine models, the most commonly used in vivo system, provide a physiologic context for the study of specific genes. These systems have provided deep insights into the role of genetic translocations, mutations, and dysregulated gene expression on leukemia pathogenesis. This review focuses on the phenotype of newly identified genes, including NPM1, IDH1/2, TET2, MLL, DNMT3A, EZH2, EED, and ASXL1, in mouse models and the implications on AML biology.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Ashley M. Perry, Eyal C. Attar,